Patient motivation for participating in clinical trials for depression: validation of the motivation for clinical trials inventory-depression

被引:9
|
作者
Andresen, Emily L. [1 ,2 ]
Wilson, Kimberly A. [1 ]
Castillo, Adelaida [1 ]
Koopman, Cheryl [1 ]
机构
[1] Stanford Univ, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA
[2] Palo Alto Univ, Pacific Grad Sch Psychol, Palo Alto, CA USA
关键词
depression; measure; motivation; randomized clinical trial; recruitment; RANDOMIZED CONTROLLED-TRIAL; PSYCHIATRIC-DISORDERS; ECONOMIC BURDEN; PATIENTS POINT; ATTITUDES; ANTIDEPRESSANTS; SCHIZOPHRENIA; PSYCHOTHERAPY; WILLINGNESS; PREFERENCES;
D O I
10.1097/YIC.0b013e328332055c
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The motivation for clinical trials inventory-depression (MCTI-D) was developed and evaluated for assessing motivations to participate in clinical trials on depression. Sixty-four participants completed the MCTI-D: 40 individuals expressing interest in participating in a randomized clinical trial (RCT); and 24 clinic patients receiving traditional care for depression. Content validity was supported by feedback derived from a panel of experts in depression research and respondents completing the measure. The motivation most frequently endorsed for participating in an RCT was the desire to help others and/or to further science. The potential stigma associated with seeing a psychiatrist was reported to have the least influence. Patients expressed a greater likelihood to participate in RCTs that involved psychotherapy than in experimental medication or placebo-controlled trials. Data from the MCTI-D may provide useful information for depression researchers to consider as possible influences on patients' decisions about whether or not they will participate. Int Clin Psychopharmacol 25:7-16 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:7 / 16
页数:10
相关论文
共 50 条
  • [31] The Efficacy of Bibliotherapy in Depression Management: A Systematic Review of Randomized Clinical Trials
    Pannu, Arzoo
    Goyal, Ramesh K.
    Sharma, Kalicharan
    CURRENT PSYCHIATRY RESEARCH AND REVIEWS, 2024,
  • [32] Update on Recent Clinical Trials Using DBS for Treatment Refractory Depression
    Malone, Donald A.
    BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 20S - 20S
  • [33] Primary outcome reporting in adolescent depression clinical trials needs standardization
    Monsour, Andrea
    Mew, Emma J.
    Patel, Sagar
    Chee-a-tow, Alyssandra
    Saeed, Leena
    Santos, Lucia
    Courtney, Darren B.
    Watson, Priya N.
    Monga, Suneeta
    Szatmari, Peter
    Offringa, Martin
    Butcher, Nancy J.
    BMC MEDICAL RESEARCH METHODOLOGY, 2020, 20 (01)
  • [34] Primary outcome reporting in adolescent depression clinical trials needs standardization
    Andrea Monsour
    Emma J. Mew
    Sagar Patel
    Alyssandra Chee-a-tow
    Leena Saeed
    Lucia Santos
    Darren B. Courtney
    Priya N. Watson
    Suneeta Monga
    Peter Szatmari
    Martin Offringa
    Nancy J. Butcher
    BMC Medical Research Methodology, 20
  • [35] A systematic review of Chinese randomized clinical trials of SSRI treatment of depression
    Zhang, Ying
    Becker, Thomas
    Ma, Yongchun
    Koesters, Markus
    BMC PSYCHIATRY, 2014, 14
  • [36] Patient involvement in clinical trials: Motivation and expectations differ between patients and researchers involved in a trial on urinary tract infections
    Schilling I.
    Behrens H.
    Hugenschmidt C.
    Liedtke J.
    Schmiemann G.
    Gerhardus A.
    Research Involvement and Engagement, 5 (1)
  • [37] Randomized clinical trials underestimate the efficacy of antidepressants in less severe depression
    Isacsson, G.
    Adler, M.
    ACTA PSYCHIATRICA SCANDINAVICA, 2012, 125 (06) : 453 - 459
  • [38] Understanding Activity Limitations in Depression Integrating the Concepts of Motivation and Volition From Health Psychology Into Clinical Psychology
    Kraemer, Lena Violetta
    Helmes, Almut Wiebke
    Bengel, Juergen
    EUROPEAN PSYCHOLOGIST, 2014, 19 (04) : 278 - 288
  • [39] The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE-II randomized clinical trial
    Blumenthal, James A.
    Babyak, Michael A.
    Craighead, Wade Edward
    Davidson, Jonathan
    Hinderliter, Alan
    Hoffman, Benson
    Doraiswamy, Pudugramam Murali
    Sherwood, Andrew
    DEPRESSION AND ANXIETY, 2021, 38 (02) : 124 - 133
  • [40] Bias in the reporting of harms in clinical trials of second-generation antidepressants for depression and anxiety: A meta-analysis
    de Vries, Ymkje Anna
    Roest, Annelieke M.
    Beijers, Lian
    Turner, Erick H.
    de Jonge, Peter
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 (11) : 1752 - 1759